Head to head
BPC-157 vs GHK-Cu
Two compounds, one grading system.
On human evidence, GHK-Cu currently leads: well researched versus emerging.
01
At a glance
BPC-157Emerging
Extensive animal healing data. Essentially no controlled human trials.
298publications
0RCTs
GHK-CuWell researched
The best human evidence of any ‘cosmetic’ peptide — but topically, not injected.
195publications
2RCTs
02
Side by side
| Attribute | BPC-157 | GHK-Cu |
|---|---|---|
| Goal | Healing & repair | Skin & cosmetic |
| Evidence | Emerging | Well researched |
| Publications | 298 | 195 |
| Randomised trials | 0 | 2 |
| Sport (WADA) | S0 — prohibited | S0 — prohibited |
| US compounding | PCAC-voted for 503A review | — |
03
Claims vs data
BPC-157 — claims vs data
| Accelerates tendon and ligament healing | animal data only |
| Heals the gut lining | animal data only |
| Reverses existing injury in humans | overreach |
| Well tolerated in reported use | partially true |
GHK-Cu — claims vs data
| Improves skin appearance (topical) | supported |
| Stimulates collagen | partially true |
| Injected equals topical benefit | weak evidence |